Retinoid pathway and cancer therapeutics.

Advanced Drug Delivery Reviews
Nathan Bushue, Yu-Jui Yvonne Wan

Abstract

The retinoids are a class of compounds that are structurally related to vitamin A. Retinoic acid, which is the active metabolite of retinol, regulates a wide range of biological processes including development, differentiation, proliferation, and apoptosis. Retinoids exert their effects through a variety of binding proteins including cellular retinol-binding protein (CRBP), retinol-binding proteins (RBP), cellular retinoic acid-binding protein (CRABP), and nuclear receptors i.e. retinoic acid receptor (RAR) and retinoid x receptor (RXR). Because of the pleiotropic effects of retinoids, understanding the function of these binding proteins and nuclear receptors assists us in developing compounds that have specific effects. This review summarizes our current understanding of how retinoids are processed and act with an emphasis on the application of retinoids in cancer treatment and prevention.

References

Sep 1, 1991·Genes, Chromosomes & Cancer·B HouleW E Bradley
Dec 13, 1991·Science·J BuckU Hämmerling
Jan 1, 1991·Skin Pharmacology : the Official Journal of the Skin Pharmacology Society·M BouclierC N Hensby
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D A GreenhalghS H Yuspa
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A LederP Leder
Sep 1, 1990·The Journal of Clinical Endocrinology and Metabolism·A J Van HerleG J Juillard
Dec 17, 1987·Nature·V GiguereR M Evans
Feb 1, 1986·Carcinogenesis·D L McCormick, R C Moon
Feb 1, 1985·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·J D PaulsonD Newman
Nov 15, 1995·Journal of the National Cancer Institute·R Lotan
Dec 1, 1995·Journal of Cellular Physiology·X S LiA K Rishi
Jul 1, 1995·The Biochemical Journal·Z S ZhengJ H Prystowsky
Sep 1, 1994·The Journal of Clinical Endocrinology and Metabolism·R SchreckJ Köhrle
Apr 14, 1994·The New England Journal of Medicine·UNKNOWN Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group
May 21, 1993·Cell·D LohnesP Chambon
Aug 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·T LufkinP Chambon
Jan 1, 1993·American Journal of Otolaryngology·N De VriesU Pastorino
Dec 15, 1995·Cell·D J Mangelsdorf, R M Evans
Jan 1, 1996·Genes & Development·P KastnerP Chambon
May 2, 1996·The New England Journal of Medicine·G S OmennS Hammar
Mar 1, 1996·Journal of the American Academy of Dermatology·J M GeigerJ H Saurat
May 14, 1996·Proceedings of the National Academy of Sciences of the United States of America·C C AchkarL J Gudas
Feb 19, 1996·Mutation Research·X K ZhangM O Lee
Jul 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·F FormelliJ A Olson
Jul 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R Lotan
Sep 1, 1996·Clinical Immunology and Immunopathology·J L Napoli
Dec 4, 1996·Biochemical and Biophysical Research Communications·J BrocardP Chambon
May 27, 1997·Proceedings of the National Academy of Sciences of the United States of America·C HuangZ Dong
Nov 14, 1997·Science·W K Hong, M B Sporn

❮ Previous
Next ❯

Citations

Feb 26, 2013·European Journal of Medicinal Chemistry·Zhi-Gang WangYing Su
Nov 26, 2013·Chemical Reviews·Rosana ÁlvarezÁngel R de Lera
Dec 7, 2013·Chemical Reviews·Pengxiang HuangFraydoon Rastinejad
Nov 19, 2013·Journal of Medicinal Food·Olmiro Cezimbra de Souza FilhoIvana Beatrice Mânica da Cruz
May 24, 2012·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·M IontaG M Machado-Santelli
Aug 21, 2012·Cancer Management and Research·Anthony R Mawson
Mar 29, 2014·International Journal of Oncology·Maria F ArisiSandra V Fernandez
Feb 15, 2014·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Eduarda SchultzeTiago Collares
Mar 7, 2014·Pathology Oncology Research : POR·Ekaterina S KropotovaTamara D Mashkova
Aug 12, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Serap YalçinUfuk Gündüz
Jul 22, 2014·Cancer Letters·Mariana P C RibeiroJosé B A Custódio
Sep 28, 2014·BMC Cancer·Padmamalini ThulasiramanImran Q Mohiudddin
Aug 26, 2014·BioMed Research International·Susana MachadoGabriela A Silva
Jan 17, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roisin M ConnollySaraswati Sukumar
Jul 12, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Young-Sam Keum, Bu Young Choi
Dec 15, 2015·Naunyn-Schmiedeberg's Archives of Pharmacology·Abdelrahman M ElsayedMohamed S Abdel-Bakky
Jun 1, 2013·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Radosław JanuchowskiMaciej Zabel
Sep 18, 2012·Pharmacology & Therapeutics·Shannon HealyJames R Davie
Mar 26, 2015·Preparative Biochemistry & Biotechnology·Claudia KochJohann Bauer
Aug 15, 2015·Endocrine·Pulak R MannaKevin Pruitt
May 31, 2011·Pharmacology & Therapeutics·Zoe RaglowYu-Jui Yvonne Wan
May 20, 2015·Steroids·Andrzej T SlominskiRobert C Tuckey
Oct 13, 2011·American Journal of Hematology·Ryan A Wilcox
Feb 15, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hui YangYu-Jui Yvonne Wan
Apr 12, 2014·Journal of Cellular and Molecular Medicine·Marina Inés FlaminiLaura María Vargas-Roig
Jan 29, 2016·Cell Biology International·Nikolay N Kalitin, Aida F Karamysheva
Jun 4, 2014·Experimental Dermatology·Andrzej T SlominskiRobert C Tuckey
Sep 1, 2015·Cancer Letters·Xia XuKai Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.